arckit-uk-mdr-classification

Medical device classification for software-as-a-medical-device is determined by evaluating the intended use statement against UK MDR 2002 and EU MDR 2017/745 rules to assign a risk class from I to III.

Determining conformity assessment pathways for AI-as-a-medical-device involves mapping the assigned risk classification to required UKCA or CE marking routes, which dictates whether Notified Body involvement is required for market access.

The conformity assessment process for software-as-a-medical-device under MHRA regulations integrates project-specific intended use statements with authoritative guidance to identify classification, marking pathways, and post-market obligations.

Clinical diagnostic software intended for therapeutic or diagnostic purposes requires regulatory compliance evaluation under EU MDR 2017/745 to determine its medical device classification and applicable conformity assessment route.

Intended use statements provide the foundational inputs for medical device classification, allowing the regulatory assessment to evaluate specific clinical purposes against UK and EU frameworks to produce a comprehensive compliance result.

Automated medical device regulatory classification for SaMD relies entirely on the accuracy of the provided intended use statement and authoritative MHRA and EU guidance, requiring manual verification for complex clinical edge cases.